Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
-
Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
-
ClearBridge Energy Midstream Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of January 31, 2025
-
Express Invites You to "Dress to Express" with Launch of New Brand Platform
-
GAN Announces Extension of SEGA SAMMY Merger Agreement
-
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
-
FIS Continues Awards Momentum With New Chartis Research Accolades for Lending and Credit Risk Solutions
-
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
-
Fitell Corporation Announces $10.0 Million Registered Direct Offering
-
Gray Media Launches New NEXTGEN TV Enhancements for the Big Game on Sunday
-
ARMLOGI HOLDING CORP. TO ANNOUNCE FISCAL 2025 SECOND QUARTER AND SIX-MONTH RESULTS ON THURSDAY, FEBRUARY 13
-
LiveOne (NASDAQ: LVO) to Announce Third Quarter Fiscal Year 2025 Financial Results and Host Investor Webcast on Friday, February 14, 2025
-
Marcus & Millichap Declares Regular Semi-Annual Dividend of $0.25 Per Share
-
Byrna Technologies Reports Record Results for Fiscal Fourth Quarter and Full Year 2024
-
Enlightify Inc. Announces Strategic Partnership with Gaintime Fund to Advance Global Renewable Energy Projects
-
Full House Resorts Announces Fourth Quarter Earnings Release Date
-
Foremost Clean Energy Announces Commencement of Trading of its Spin-Out, Rio Grande Resources
-
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conferenc
-
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
-
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
-
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
-
CLEAR Launches New Lanes at Portland International Airport
-
Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2024 Results on March 5, 2025
-
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
-
Empower Achieves Record Base Earnings of $973M in 2024, up 30% From Prior Year
-
Stelia Announced as Gold Sponsor for NVIDIA GTC, Showcasing Hyperband and Leading AI Scalability Discussion
-
Shark Beauty™ Revolutionizes at-home Skincare with CryoGlow™, the only iQLED Anti-Aging & Skin Clearing Face Mask with InstaChill Undereye Cooling
-
Alliance Witan PLC - Net Asset Value
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
-
Viral All-Teen '355 The Musical' to Debut at Tony-Award Winning Theater 54 Below
-
Ekspress Grupp disputes the Lithuanian Competition Council's decision regarding Lrytas acquisition
-
OTC Wiki Announces Successful Beta Launch and Significant Milestones
-
Annual Financial Report 2024
-
REPUBLIC OF URUGUAY - ANNOUNCEMENT OF TENDER OFFER RESULTS
-
Meridianbet (GMGI) Listed on Oracle’s Global Tech Reference Page
-
COMPOST GENIE® RECOGNIZED AS 2025 PRODUCT OF THE YEAR USA
-
SEON Announces Executive Appointments to Propel Next Phase of Growth
-
Chongqing, London Residents Interact in Real-Time Through Screen
-
CoinEx Launches New Slogan "Your Crypto Trading Expert," Leading a New Era in Crypto Trading Services
-
CoinEx Launches New Slogan "Your Crypto Trading Expert," Leading a New Era in Crypto Trading Services
-
FTAI INVESTOR DEADLINE: FTAI Aviation Ltd. Investors are Alerted to Contact BFA Law before the Imminent March 18 Class Action Deadline
-
BIOA INVESTOR DEADLINE: BioAge Investors are Alerted to Contact BFA Law before the Imminent March 10 Class Action Deadline
-
APLT INVESTOR DEADLINE: Applied Therapeutics Investors are Alerted to Contact BFA Law before the Imminent February 18 Class Action Deadline
-
TMDX INVESTOR NEWS: TransMedics Group Investors are Alerted to Contact BFA Law about the Pending Securities Fraud Investigation
-
NXT INVESTOR DEADLINE: Nextracker Inc. Investors are Alerted to Contact BFA Law before the Imminent February 25 Class Action Deadline
-
NVO INVESTOR DEADLINE: Novo Nordisk Investors are Alerted to Contact BFA Law before the Imminent March 25 Class Action Deadline
-
MQ DEADLINE TODAY: Marqeta, Inc. Investors with Losses are Alerted to Contact BFA Law before Today's Class Action Deadline
-
CROX INVESTOR DEADLINE: Crocs, Inc. Investors are Alerted to Contact BFA Law before the Imminent March 24 Class Action Deadline
-
Northwest Healthcare Properties Real Estate Investment Trust Announces Timing for Fourth Quarter and Year End 2024 Results
